Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Diabetes Mellitus, Type 1 (Phase 2)
Genetic Diseases, Inborn (Phase 2)
Muscular Diseases (Phase 2)
Muscular Disorders, Atrophic (Phase 2)
Muscular Dystrophies (Phase 2)
Musculoskeletal Diseases (Phase 2)
Myotonia (Phase 1/Phase 2)
Myotonic Disorders (Phase 2)
Myotonic Dystrophy (Phase 2)
Nervous System Diseases (Phase 2)
Neurodegenerative Diseases (Phase 2)
Neuromuscular Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue